Role of occupational health services in workplace drug testing

Lillsunde, Pirjo; Mukala, Kristiina; Partinen, Ritva; Lamberg, Matti

doi:10.1016/j.forsciint.2007.03.007

Cited by 7 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is however the role of occupational health professionals to ensure that these control measures are taken keeping in view ethical concerns, e.g. confidentiality or right to privacy, and are not seen as the only answer to a problem much more complex [6][7][8][9][10][11][12].…”

Section: Resultsmentioning

confidence: 99%

Occupational workplace and traffic fatalities in Alsace, France (2000–2005): Results of toxicological investigations

Szwarc

Tracqui

Ludes

et al. 2009

Forensic Science International Supplement Series

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Occupational workplace and traffic fatalities in Alsace, France (2000–2005): Results of toxicological investigations

Szwarc

Tracqui

Ludes

et al. 2009

Forensic Science International Supplement Series

View full text Add to dashboard Cite

“…The employer must have a written occupational health care and occupational health care needs based on workplace conditions. Alcohol and drug problems should be considered as health problems and they should be dealt with the same way as any other health problem at work [43]. In Norway, WDT is mainly done within the transport, petrochemical, shipping, automobile, pharmaceutical and computer industries, by mutual agreement between the employee and the company [44].…”

Section: Workplace Drug Testingmentioning

confidence: 99%

Workplace Drug Testing: An Overview of the Current Situation

2016

J Toxins

View full text Add to dashboard Cite

Background: Almost a quarter of the adult population in the European Union are estimated to have used illicit drugs at some point in their lives. Since these substances can be found at home, on the road, in leisure, it can be assumed that also exist in the workplace, even if they are more difficult to detect. In the workplace, psychoactive substances use may have important implications for workers, thus affecting the tasks to be carried out in their work environment.Objective: This article reviews how the different countries implement the workplace drug testing (WDT) as necessary tool in order to play a deterrent role on the abuse behavior.Discussion: At a European level there is no specific legislation on drug testing at the workplace. WDT is performed on a much smaller scale than in the United States, though it is on the increase. It is also important to discriminate between workers under the influence of these substances at work than those who consume regularly but are not under the influence of drugs at work. In conclusion we can say that there is a growing interest in WDT, but the costs and benefits that these controls may represent remain unknown.

show abstract

“…Regarding the consumption of other psychoactive substances in the workplace, the information is scarcer, with Cannabis being more prevalent among younger workers, whereas cocaine is more prevalent among highly skilled workers such as managers [7]. Indeed, because workplace drug testing is often performed on-site by occupational physicians, a global statistic spectrum is hard to obtain [8].…”

Section: Introductionmentioning

confidence: 99%

Abuse of Licit and Illicit Psychoactive Substances in the Workplace: Medical, Toxicological, and Forensic Aspects

Dinis-Oliveira

Magalhães

2020

JCM

View full text Add to dashboard Cite

About one-third of adult life is spent in the workplace. The use of psychoactive substances is a major preventable cause of morbidity and mortality. The consumption of psychoactive substances during or outside working hours greatly increases the frequency and severity of labor accidents, as well as the workers’ poor general state of health and productivity, implying higher costs for enterprises. It is the responsibility of organizations to ensure the safety and health of their workers. These cannot be limited to traditional routine clinical exams, as other aspects also have an impact on health. Thus, prevention and intervention in the consumption of psychoactive substances (e.g., ethanol, opioids, central nervous system stimulants or depressants, hallucinogens, Cannabis derivatives, dissociative substances, and inhalants) in labor activity should be considered as an investment of organizations and not as a cost, in view of the professional, personal, and family advantages for workers and employers, with a potential impact on productivity, security, health, and quality of life at work. Despite the extensive literature on the subject, each article generally focuses on one or another aspect of a very specific nature, not tackling the problem in a holistic way by confronting clinical, safety, and legal issues. This article presents a reflection on the legal, laboratorial, clinical, ethical, forensic, and safety concerns related to the consumption of psychoactive substances in the workplace, and can be a cross-cutting contribution to occupational medicine, forensic medicine, and insurance medicine, as well as for entrepreneurs, lawyers, judges, workers, and technicians from the public and private sectors that develop projects in this area. This discussion is based on general principles established internationally and highlights the role of the occupational healthcare system and other decision-making actors in the prevention and supervision of workplace psychoactive consumption.

show abstract

Role of occupational health services in workplace drug testing

Cited by 7 publications

References 0 publications

Occupational workplace and traffic fatalities in Alsace, France (2000–2005): Results of toxicological investigations

Occupational workplace and traffic fatalities in Alsace, France (2000–2005): Results of toxicological investigations

Workplace Drug Testing: An Overview of the Current Situation

Abuse of Licit and Illicit Psychoactive Substances in the Workplace: Medical, Toxicological, and Forensic Aspects

Contact Info

Product

Resources

About